AHAllyson G. Hall

Allyson G. Hall

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Allyson G. Hall has a total of 138 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • ED-to-Home Intervention More Effective for Patients Who Are Socioeconomically Disadvantaged

    by Jessica R. Schumacher, Kristen Turner, Dawn Rosini, Jeffrey S. Harman, Allyson G. Hall, Heidi S. Kinsell, Barbara J. Lutz, Phyllis Hendry, Donna L. Carden

    Background: Studies to reduce hospital-based acute care have not considered whether interventions are more effective in targeted populations. Our objective was to determine the differential effectiveness of an ED-to-Home transitional care intervention on hospital-based acute care based on socioeconomic disadvantage. Research Design: Randomized clinical trial assessed the impact of an ED-to-Home transitional care intervention on hospital-based acute care [return emergency department (ED) visits or hospitalizations] within 30 and 60 days of the index ED visit at 2 ED tertiary referral centers in 2014–2015. Subjects: Older, chronically ill ED visitors scheduled for ED discharge, hospital observation, or with frequent ED visits. Intervention: Adapted Coleman Care Transitions Intervention. Intervention arm was interacted with measures of socioeconomic disadvantage [nonwhite race, Medicaid eligibility (low income), or neighborhood disadvantage determined by area deprivation index, or any vs. none of these measures] to assess differential intervention effectiveness. Outcome Measures: Hospital-based acute care after index ED visit determined by Medicare claims. Results: A total of 1101 patients were enrolled. Patients in the Intervention group with “any disadvantage” had 52% lower odds (OR=0.52; P =0.04) of hospital-based acute care within 60 days of index ED visit compared with usual care participants without disadvantage. The Intervention did not reduce hospital-based acute care in participants without disadvantage. Conclusions: The ED-to-Home Intervention reduced return ED visits and hospitalizations when measures of socioeconomic disadvantage were considered. It did not reduce these visits for those without disadvantage. These measures are visible in real-time and could be used to target the Intervention to patients most likely to benefit.

  • Open Access

    Association between social vulnerability and surgical site infection across surgical procedures

    by Molly E. Fleece, Russell L. Griffin, Reid M. Eagleson, Robert E. Nichols, Mary M. Duncan, Shiney Isaac, Catina L. James, Allyson G. Hall, Rachael A. Lee

    Objective: To evaluate the association between neighborhood-level social vulnerability and risk of surgical site infection. Design: Retrospective cohort study from January 1, 2019-December 31, 2024 Setting: Large academic hospital in the Deep South Participants: Patients undergoing NHSN-defined procedures by CPT coding (coronary artery bypass graft, colon surgery, craniotomy, spinal fusion, hip prosthesis, knee prosthesis, or abdominal hysterectomy) were included. Social vulnerability index (SVI) percentile and themes were defined by the Centers for Disease Control and Prevention criteria and assigned based on residential ZIP code. Methods: The primary outcome was development of SSI. Cox proportional hazards models stratified by SSI surveillance duration (30 or 90 days) were used to estimate hazard ratios (HRs) and 95% confidence intervals, adjusting for demographic, clinical, and procedural characteristics. Results: Among 40,954 surgeries, 26,067 patients (63.7%) resided in high SVI ZIP codes. The risk of SSI increased across SVI tertiles (low 1.5%, medium 2.2%, high 2.4%). Compared with those in low SVI tertile, SSI risk was higher for patients in the medium-SVI (aHR 1.40, 95% CI 1.03–1.92) and high-SVI tertile (aHR 1.49, 95% CI 1.10–2.01). Higher SVI socioeconomic status was associated with increased SSI risk (aHR 1.33, 95% CI 1.07–1.64) and higher housing and transportation vulnerability was associated with increased deep incisional and organ space SSI. Conclusions: Higher neighborhood-level SVI was independently associated with increased risk of SSI across a broad surgical population in the South. Incorporating SVI into preoperative risk assessment may allow targeted infection prevention strategies for hospitals to address barriers to care.

  • Open Access

    Factors Associated with Trust and Likelihood of Participation in Pandemic-Related Clinical Trials Among Blacks in the U.S. Deep South

    by Barbara Hansen, Lori Brand Bateman, Melissa Ryan, Rekha Ramachandran, Tiffany Osborne, Mona N. Fouad, Suzanne E. Judd, Young-Il Kim, William A. Anderson, Allyson G. Hall

    Recruitment for clinical trials among Black populations in the U.S. Deep South is challenging due to general distrust of medical research. The COVID-19 pandemic exacerbated this phenomenon at a time when distrust of the medical community was high. This study evaluated the likelihood of participation in a COVID-19 clinical trial among Black residents in urban and rural counties in the State of Alabama. From 3 counties, 296 participants were queried regarding their awareness of COVID-19 clinical trials, likelihood of participating, medical mistrust, experience with racism, and trust in sources of COVID-19 information. Bivariate analyses compared data by county. A multivariate regression model estimated likelihood of participation in a COVID-19 clinical trial. Participants were majority female (76.9%) with 35% likely to participate; however, only 28.4% were aware of research in their area. Participants’ trust in sources of COVID-19 information varied significantly by county ( p < 0.001) with rural residents least trustful of information from local health clinics and researchers. Urban residents were least trustful of information from pharmaceutical companies. Multivariate analyses identified two significant predictors increasing likelihood of participation: trust in government clinical trial information ( p < 0.001), and awareness of clinical trials in participants’ areas ( p = 0.02); trust in information from pharmaceutical companies, agreement that racial discrimination occurs in doctor’s offices, and household income ( p < 0.05) decreased likelihood of participation. Trust and racial discrimination remain primary drivers of low Black clinical trial participation. Recruitment approaches for clinical trials on emergent viral infections should be individualized for each population and locale, built around developing and maintaining trust.

  • Machine learning-driven risk prediction for post-hospitalization diabetes case management: Integrating clinical and social determinants of health

    by Seung-Yup Lee, Mohammad Saleem, Andrew M. Land, Erin W. DeLaney, Alison R. Garretson, Mahee Patel, Allyson G. Hall, Salisa Westrick, Fernando Ovalle, Andrea L. Cherrington, et al.


  • Open Access

    Real-world Implementation and Outcomes of Artificial Intelligence in Healthcare Supply Chains: A Systematic Review (Preprint)

    by Mahdieh Zare Bidoki, Seung Yup Lee, Mohammed Saleem, Pavan Kumar Ashok, Allyson G. Hall, Larry R. Herald, Akanksha Singh

    BACKGROUND Healthcare supply chains face persistent challenges such as information asymmetry, fragmented coordination, and limited technological integration, vulnerabilities starkly exposed during the COVID-19 pandemic. While artificial intelligence (AI) has shown promise in clinical applications, its use in healthcare supply chain management remains understudied. OBJECTIVE This systematic review examined the extent to which AI implementation in healthcare supply chain management (SCM) has been evaluated in the peer-reviewed literature, focusing on: (1) types of AI tools reported as implemented in real-world settings, (2) the degree to which implementation science frameworks were applied in these deployments, and (3) operational outcomes reported following implementation. METHODS Following PRISMA 2020 guidelines, three electronic databases (PubMed, Scopus, and Web of Science) were searched on April 9, 2024, using keywords related to implementation science, artificial intelligence, healthcare, and supply chain management. Searches were limited to English-language, peer-reviewed articles published between 2009 and 2024. Six reviewers independently screened 5,499 unique records using predefined inclusion and exclusion criteria. Studies were included only if they documented actual AI implementation beyond pre-implementation modeling or simulation. Data extraction focused on study characteristics, AI implementation contexts, supply chain domains, implementation science framework use, and reported outcomes. RESULTS From 5,499 initial unique records, 54 proceeded to full-text review; only 3 met final inclusion criteria, a 99.95% exclusion rate, revealing a fundamental gap between widespread industry AI adoption and rigorous research on the implementation of AI across supply chain functions. The three included studies reported on AI implementation across distinct supply chain functions: laboratory specimen transport optimization (genetic algorithms achieving 20-30% cost savings while maintaining ISO quality standards), acute stroke care coordination (machine learning-enabled platform reducing door-to-treatment times by 32-39% and communication burden by 30%), and integrated smart hospital operations (comprehensive AI platform supporting >12,000 daily uses with sub-second response times). While all implementations demonstrated measurable operational improvements, none employed formal implementation science frameworks (e.g., CFIR, RE-AIM, NASSS) to guide planning or evaluation, and follow-up periods were limited to six months or less in the studies that reported them. CONCLUSIONS This review reveals a critical paradox: despite widespread industry AI adoption in the healthcare supply chain, the implementation evidence is absent. The lack of implementation research shows more than a methodological gap; it signals substantial risk for healthcare organizations looking to implement AI without evidence-based guidance on the implementation process, organizational prerequisites, or sustainability factors. Future research must prioritize implementation science approaches, longitudinal sustainability assessment, and evaluation of downstream patient outcomes. Interdisciplinary collaboration between engineers, healthcare managers, and implementation scientists is essential to transform AI from a promising concept into an equitable, sustainable component of healthcare supply chain operations.

  • Association of Hospitals' Organizational Characteristics and Market Factors Offering Integrative Medicine Services to Adult Patients With Cancer

    by Sanober Ajani, Kristine Ria Hearld, Soumya J. Niranjan, Allyson Hall, Gabriel Lopez, Nancy Borkowski

    PURPOSE: Demand for integrative medicine (IM) in cancer care is increasing, yet limited data exist regarding which hospitals offer IM services and what those services include. This exploratory cross-sectional study aimed to (1) examine organizational characteristics and market factors of cancer hospitals that offered IM services and those that did not; and (2) identify the types of services included in IM programs within cancer hospitals and their funding sources. METHODS: Bivariate analysis evaluated the relationship between the dependent variable (cancer hospitals offering IM services) and the independent categorical variables. χ 2 tests were performed for categorical variables, and t tests were used to compare means for continuous variables. An electronic survey was developed and distributed to 150 IM program leaders. The survey assessed service offerings, delivery settings, referrals, funding, barriers, and facilitators. Descriptive statistics were used to summarize and describe survey results. Results: Key findings showed statistically significant associations between cancer hospitals providing IM services and those that did not. A higher proportion of cancer hospitals with IM programs offered palliative care services, were not-for-profit, larger (bed size 400+), teaching entities located in metropolitan areas with larger populations and higher per capita income. Most frequently offered IM services were nutrition counseling, acupuncture, and massage therapy. Additionally, philanthropy was essential in providing financial support for IM services. CONCLUSION: This study emphasizes the need for a better understanding of the factors influencing the availability and accessibility of IM services in cancer care. IM programs are increasingly embedded within cancer centers, offering diverse services to support patients' symptom management and quality of life. However, funding, staffing, and integration variations reflect a need for standardized models and best practices.


  • Open Access

    Integrating Social Determinants of Health in Machine Learning–Driven Decision Support for Diabetes Case Management: Protocol for a Sequential Mixed Methods Study

    by Seung-Yup Lee, Leslie W Hayes, Bunyamin Ozaydin, Steven Howard, Alison M Garretson, Heather M Bradley, Andrew M Land, Erin W DeLaney, Amy O Pritchett, Amanda L Furr, et al.

    Background: The use of both clinical factors and social determinants of health (SDoH) in referral decision-making for case management may improve optimal use of resources and reduce outcome disparities among patients with diabetes. Objective: This study proposes the development of a data-driven decision-support system incorporating interactions between clinical factors and SDoH into an algorithm for prioritizing who receives case management services. The paper presents a design for prediction validation and preimplementation assessment that uses a mixed methods approach to guide the implementation of the system. Methods: Our study setting is a large, tertiary care academic medical center in the Deep South of the United States, where SDoH contribute to disparities in diabetes-specific hospitalizations and emergency department (ED) visits. This project will develop an interpretable artificial intelligence model for a population with diabetes using SDoH and clinical data to identify which posthospitalization cases have a higher likelihood of subsequent ED use. The electronic health record data collected for the study include demographics, SDoH, comorbidities, hospitalization-related factors, laboratory test results, and medication use to predict posthospitalization ED visits. Subsequently, a mixed methods approach will be used to validate prediction outcomes and develop an implementation strategy from insights into patient outcomes from case managers, clinicians, and quality and patient safety experts. Results: As of December 2023, we had abstracted data on 174,871 inpatient encounters between January 2018 and September 2023, involving 89,355 unique inpatients meeting inclusion criteria. Both clinical and SDoH data items were included for these patient encounters. In total, 85% of the inpatient visits (N=148,640) will be used for training (learning from the data) and the remaining 26,231 inpatient visits will be used for mixed-methods validation (testing). Conclusions: By integrating a critical suite of SDoH with clinical data related to diabetes, the proposed data-driven risk stratification model can enable individualized risk estimation and inform health professionals (eg, case managers) about the risk of patients’ upcoming ED use. The prediction outcome could potentially automate case management referrals, helping to better prioritize services. By taking a mixed methods approach, we aim to align the model with the hospital’s specific quality and patient safety considerations for the quality of patient care and the optimization of case management resource allocation. International Registered Report Identifier (IRRID): DERR1-10.2196/56049


  • Partnering With Churches to Address COVID-19 Vaccine Hesitancy and Uptake in Trustworthy Contexts

    by Lori B. Bateman, Allyson Hall, Lonnie Hannon, Melissa Ryan, Tiffany Osborne, Samantha Whitfield, Grace Okoro, Catanya Stager, Susan Driggers, Valerie Jones, et al.

    The Black church has long been seen as a crucial partner in addressing public health issues. This paper describes the development, implementation, and evaluation of a community-engaged church intervention addressing COVID-19 vaccine hesitancy in underserved Black communities in Jefferson County, Alabama. We partnered with churches to implement and evaluate the intervention between March and June of 2022 and found that our church partners were capable of significant messaging reach, particularly through electronic means. ( Am J Public Health. 2024;114(S5):S392–S395. https://doi.org/10.2105/AJPH.2024.307683 )


  • Improving Communication with Family Members during a Global Pandemic: Effect on Patient Experience

    by Gregory N. Orewa, Sue S. Feldman, Kierstin Cates Kennedy, Allyson G. Hall, Yu H. Cheng, Arnaz A. Malone, Ernest O. Grimes, Kristine Ria Hearld, Ph D, Mba, et al.

    Objectives: Communication with patients and their families/caregivers to facilitate informed decision making is an integral part of patient/family-centered care. Due to the high coronavirus disease 2019 (COVID-19) infection rates and limited personal protective equipment, healthcare systems were forced to restrict patient visitors, limit patient–provider interactions, and implement other...